iiinova — where your digital self keeps evolving

Blood Journals Portfolio @bloodjournals.hematology.org · 09/09/2026

New issue of Blood Global Hematology out now featuring Inequities in clinical trial availability in Europe, The correlation between Hb and the clinical spectrum of SCA, Rethinking Hispanic/Latino as an ethnic category in leukemia research and more. Explore here: ashpublications.org/bloodglobal/...

000 0

Blood Journals Portfolio @bloodjournals.hematology.org · 03/09/2026

New issue of Blood out now featuring The hidden role of neutrophils in steroid-resistant GVHD, IL-16 drives a novel pathway of BTK inhibitor resistance, Precision transfusion medicine in the omics era and more. Explore here: ashpublications.org/blood/issue/...

000 0

Blood Journals Portfolio @bloodjournals.hematology.org · 31/08/2026

New issue of Blood Neoplasia is out featuring Co-option of lineage plasticity as a hallmark of multipotent acute leukemias, Autologous transplant for patients with chemotherapy-sensitive late relapse of diffuse large B-cell lymphoma and more. Explore here: ashpublications.org/bloodneoplas...

000 0

Blood Journals Portfolio @bloodjournals.hematology.org · 27/08/2026

New issue of Blood VTH out now! Featuring New insights into flavonoid binding to the thromboxane A2 receptor, Sirolimus outperforms alpelisib in models of NRASQ61R-driven vascular overgrowth, and more. Explore here: ashpublications.org/bloodvth/iss...

000 0

Blood Journals Portfolio @bloodjournals.hematology.org · 06/08/2026

New issue of Blood out now featuring Discovery and preclinical activity of ziftomenib, Single-day nonactivated IL-18 CAR T-cell therapy, RAASi and anemia in SCD, and more. Explore here: ashpublications.org/blood/issue/...

010 1

Blood Journals Portfolio @bloodjournals.hematology.org · 30/07/2026

New issue of Blood out now featuring Epigenetic toggling between multipotency and differentiation, Nanotube trafficking fuels myeloma bone loss, Promises and potential pitfalls of in vivo CAR gene therapy, and more. Explore here: ashpublications.org/blood/issue/...

000 0

Blood Journals Portfolio @bloodjournals.hematology.org · 23/07/2026

New issue of Blood out now featuring ASH HematOmics Program, Clinical spectrum of hereditary hemorrhagic telangiectasia, RNF217 modulates iron metabolism, and more. Explore here: ashpublications.org/blood/issue/...

000 0

Blood Journals Portfolio @bloodjournals.hematology.org · 16/07/2026

New issue of Blood out now featuring OutFOXing a FENDRR bender in T-ALL, Crossing the trial-practice chasm in CAR-T for relapsed LBCL, Oxidized PDI promotes thrombus formation, and more. Explore here: ashpublications.org/blood/issue/...

030 3

Blood Journals Portfolio @bloodjournals.hematology.org · 10/07/2026

New issue of Blood out now featuring MDM4-related bone marrow failure, Pavurutamab in relapsed myeloma, Phenotype-driven analysis of PIEZO1 variants, and more. Explore here: ashpublications.org/blood/issue/...

010 1

Blood Journals Portfolio @bloodjournals.hematology.org · 01/07/2026

We're thrilled to welcome a new Associate Editor to Blood today! Dr. Omar Abdel-Wahab is the Evnin Family Chair of Molecular Pharmacology at @mskcancercenter.bsky.social where he also serves as Chair of the Molecular Pharmacology Program in the Sloan Kettering Institute. #NewEditor

042 4

Blood Journals Portfolio @bloodjournals.hematology.org · 25/06/2026

New issue of Blood out now featuring Freeze-dried platelets for traumatic brain injury, Clonal evolution of NPM1-mutated AML, Iron overload rewires HSC metabolism, and more. Explore here: ashpublications.org/blood/issue/...

020 2

Blood Journals Portfolio @bloodjournals.hematology.org · 23/06/2026

New issue of Blood Advances out now featuring Eligibility versus appropriateness in allogeneic HCT, Targeting erythroid cell–derived asparagine inhibits alloimmunization in sickle cell disease, Remission with residuals, but no cure and more. Explore here: ashpublications.org/bloodadvance...

010 1

Blood Journals Portfolio @bloodjournals.hematology.org · 22/06/2026

New issue of Blood RCI out now featuring Red blood cells as sensors of stress in ultramarathons, Emerging concepts in sickle cell disease acute chest syndrome, Iron-refractory iron deficiency anemia and more. Explore here: ashpublications.org/bloodrci/iss...

000 0

Blood Journals Portfolio @bloodjournals.hematology.org · 18/06/2026

New issue of Blood out now! Featuring Immune-mediated side effects of cancer immunotherapies, The prevalence and clinical significance of clonal monocytosis, and more. Explore here: ashpublications.org/blood/issue/...

010 1

Blood Journals Portfolio @bloodjournals.hematology.org · 17/06/2026

We're proud to share that Blood has a JIF of 23.9 and continues its position as the most-cited journal in hematology, with 168,805 total citations in 2025. Blood Advances' JIF is 7.7. With 26,750 citations in 2025, it's among the top ten most cited hematology journals. #JCR2026

030 3

Blood Journals Portfolio @bloodjournals.hematology.org · 11/06/2026

New issue of Blood out now featuring Ven-aza and the bone marrow niche, Complement activation in ITP, CD7 CAR T cells for relapsed/refractory AML, and more. Explore here: ashpublications.org/blood/issue/...

010 1

Blood Journals Portfolio @bloodjournals.hematology.org · 10/06/2026

New issue of Blood Global Hematology out now! Featuring Developing nations’ guide to Hodgkin lymphoma, The challenge of treating African children with hydroxyurea, Sickle cell disease: then and now, and more. Explore here: ashpublications.org/bloodglobal/...

010 1

Blood Journals Portfolio @bloodjournals.hematology.org · 09/06/2026

New issue of Blood Advances out now featuring Real-world experience with tabelecleucel, Management of relapsed/refractory AL amyloidosis, and more. Explore here: ashpublications.org/bloodadvance...

010 1

Blood Journals Portfolio @bloodjournals.hematology.org · 04/06/2026

New issue of Blood out now featuring Predictive markers of glofitamab resistance, CREBBP mutations and lymphomagensis, Arterial thrombosis in hypofibrinogenemia and more. Explore here: ashpublications.org/blood/issue/...

011 1

Blood Journals Portfolio @bloodjournals.hematology.org · 03/06/2026

A real-world cohort of patients with secondary #erythrocytosis had higher rates of #thrombosis compared with treated PV. Secondary erythrocytosis was associated with a higher prevalence of smoking, obesity, and diabetes mellitus. Read in Blood RCI: ow.ly/qBZZ50Z5bV7

010 1

Blood Journals Portfolio @bloodjournals.hematology.org · 02/06/2026

Sepsis-triggered proteolysis of A2 reduces cell surface fibrinolytic activity. A2 proteolysis is associated with microvasculopathic organ dysfunction in humans. Read in Blood VTH: ow.ly/BmOL50Z5cx8

000 0

Blood Journals Portfolio @bloodjournals.hematology.org · 29/05/2026

New issue of Blood out now featuring CD117-targeted HCT preconditioning in AML and MDS, CSNK1E as a key to unlocking drug persistence in DLBCL, Novel functions of WPB proteins seem to cluster with VWF and more. Explore here: ashpublications.org/blood/issue/...

000 0

Blood Journals Portfolio @bloodjournals.hematology.org · 27/05/2026

New issue of Blood Advances out now featuring CD19 CAR T cells for B-ALL with EMD, Six-year FIX-padua gene therapy in hemophilia B, Popping FVIII concentrates into an updated classification and more. Explore here: ashpublications.org/bloodadvance... #BloodAdvances

010 1

Blood Journals Portfolio @bloodjournals.hematology.org · 19/05/2026

Frontline eltrombopag plus IST is cost-effective compared with IST alone for adults with severe aplastic anemia. Incremental net monetary benefit per patient treated with frontline eltrombopag is ∼$64 000. Read in Blood RCI: ow.ly/hSk250YSvaQ #aplasticanemia #BloodRCI

020 2

Blood Journals Portfolio @bloodjournals.hematology.org · 14/05/2026

New issue of Blood out now featuring WM evolution during ibrutinib therapy, Bidirectional relationship for CHIP and IBD, Targeting DHODH in B-ALL and more. Explore here: ashpublications.org/blood/issue/... #BloodJournal #NewIssue

010 1

Blood Journals Portfolio @bloodjournals.hematology.org · 13/05/2026

PACS is a chronic thromboinflammatory disorder driven by persistent endothelial injury, immune dysregulation and coagulation imbalance. The 1-year persistence of coagulation abnormalities supports future surveillance strategies in patients with PACS. ow.ly/TM3a50YV5Og #BloodVTH #PACS

010 1

Blood Journals Portfolio @bloodjournals.hematology.org · 12/05/2026

Two multidisciplinary guideline panels prioritized 34 outcomes for 32 research questions related to ALL in AYAs. The prioritized outcomes can inform future primary studies, systematic reviews, and guidelines. Read in Blood Neoplasia: ow.ly/1tJF50YV3e8 #ALL #BloodNeoplasia

000 0

Blood Journals Portfolio @bloodjournals.hematology.org · 07/05/2026

New issue of Blood out now featuring Gene therapy for transfusion-dependent thalassemia, Long telomeres and risk of lymphoma, Role of transferrin receptors in hepcidin induction, and more. Explore here: ashpublications.org/blood/issue/...

000 0

Blood Journals Portfolio @bloodjournals.hematology.org · 06/05/2026

Genome-wide association studies identified regulatory elements controlling erythropoietin gene expression. Anemia-associated polymorphisms affect known and novel EPO hypoxia response elements. Read in Blood RCI: ow.ly/RzmZ50YStv2

010 1

Blood Journals Portfolio @bloodjournals.hematology.org · 05/05/2026

Cobicistat allowed an eightfold reduction in venetoclax while optimizing exposure, demonstrating a cost-effective strategy for AML treatment. Read in Blood Neoplasia: ow.ly/qlzN50YV53A #AML #BloodNeoplasia

010 1

Blood Journals Portfolio @bloodjournals.hematology.org · 29/04/2026

New issue of Blood Advances out now featuring Finding the genes that fit CPX-351, Investigative reporting on factor VIII whereabouts, Pregnancy after hematopoietic stem cell transplant: an international multicenter study and more. Explore here ➡️ ashpublications.org/bloodadvance...

010 1

Blood Journals Portfolio @bloodjournals.hematology.org · 29/04/2026

Get to know the previous Editor-in-Chief of Blood (2019-2024), Dr. Nancy Berliner of @harvardmed.bsky.social and @brighamandwomens.bsky.social: www.linkedin.com/feed/update/...

000 0

Blood Journals Portfolio @bloodjournals.hematology.org · 23/04/2026

New issue of #Blood out now featuring Removal of anti-ABO B cells by bispecific antibody, Common variants influence #AML risk and prognosis, a new #howItreat and more. Explore here: ashpublications.org/blood/issue/...

000 0

Blood Journals Portfolio @bloodjournals.hematology.org · 17/04/2026

It’s World Hemophilia Day! A recent study in Blood VTH examined social vulnerability, access to care, and outcomes for #hemophilia patients in the United States. Explore the findings: ashpublications.org/bloodvth/art... #WorldHemophiliaDay #WHD2026 #BloodVTH

010 1

Blood Journals Portfolio @bloodjournals.hematology.org · 14/04/2026

New issue of #BloodAdvances out now featuring Monovalent antibody treatment of von Willebrand disease, Osteocyte-derived erythroferrone regulates liver hepcidin during stress erythropoiesis, and more. Explore here: ashpublications.org/bloodadvance...

000 0

Blood Journals Portfolio @bloodjournals.hematology.org · 09/04/2026

New issue of Blood out now featuring Targeted therapy in early-stage classical Hodgkin lymphoma, How I approach clinical ethics consultation in hematology, Gastrin for the treatment of acute graft-versus-host disease of the stomach, and more. Explore here: ashpublications.org/blood/issue/...

000 0

Blood Journals Portfolio @bloodjournals.hematology.org · 07/04/2026

CAR-T therapy shows comparable survival outcomes in older and younger patients with #LBCL. In younger patients, axi-cel and liso-cel improve PFS vs tisa-cel; in older patients, axi-cel increases nonrelapse mortality vs tisa-cel. Read in Blood ICT: ow.ly/o3RH50Yz8TX

000 0

Blood Journals Portfolio @bloodjournals.hematology.org · 06/04/2026

"Diagnosis and management of AML in pediatric patients: consensus recommendations from an international expert panel." Read the special report in Blood: ow.ly/y9uP50YCt3X #AML #BloodJournal #SpecialReport

020 2

Blood Journals Portfolio @bloodjournals.hematology.org · 02/04/2026

New issue of Blood out now featuring Global access to CAR T, BelaRd in ASCT-ineligible patients with NDMM, Human HSC generation from pluripotent stem cells, and more. Explore here: ashpublications.org/blood/issue/...

010 1

Blood Journals Portfolio @bloodjournals.hematology.org · 30/03/2026

Outcomes of NPM1-mutated AML in Brazil are influenced by limited access to novel therapies and low transplantation rates. Read in Blood Global Hematology: ow.ly/K3MY50YsyfQ #AML #Brazil

010 1

Blood Journals Portfolio @bloodjournals.hematology.org · 25/03/2026

New issue of Blood ICT out now featuring Varnimcabtagene autoleucel in relapsed or refractory B-cell malignancies, CAR T-cell therapy outcomes in plasma cell leukemia, and more. Explore here: ashpublications.org/bloodict/iss...

000 0

Blood Journals Portfolio @bloodjournals.hematology.org · 24/03/2026

An important study in observance of #DVT Awareness Month! It concluded that Dasatinib, ponatinib, and nilotinib damage ECs in different ways, all of which can contribute to #arterialthrombosis. Read the full article in Blood VTH: ashpublications.org/bloodvth/art... #BloodVTH

020 2

Blood Journals Portfolio @bloodjournals.hematology.org · 24/03/2026

New issue of Blood Advances out now! Featuring Advancing systems-based hematology, A new era for heavy menstrual bleeding, The interplay of von Willebrand disease and women’s reproductive health, and more. Explore here: ashpublications.org/bloodadvance... #BloodAdvances

001 1

Blood Journals Portfolio @bloodjournals.hematology.org · 24/03/2026

Global MM incidence in AYA increased 60% (1990-2021), with males experiencing 43% higher rates and widening health inequalities. Read in Blood Global Hematology: ow.ly/Mqaw50YsxP1 #MultipleMyeloma

010 1

Blood Journals Portfolio @bloodjournals.hematology.org · 18/03/2026

New issue of Blood RCI out now! Featuring Long-distance trail running induces inflammation-associated protein, lipid, and purine oxidation in red blood cells, Sex-specific brain morphology differences in pediatric sickle cell disease, and more. Explore here: ashpublications.org/bloodrci/iss...

011 1

Blood Journals Portfolio @bloodjournals.hematology.org · 18/03/2026

We're pleased to share the ASH Consortium on Newborn Screening in Africa, recently published in Blood Advances. Through CONSA, ~175,000 infants in sub-Saharan Africa have been screened, documenting a high incidence of #SCD and trait. Read here: ashpublications.org/bloodadvance...

010 1

Blood Journals Portfolio @bloodjournals.hematology.org · 12/03/2026

Exciting news for the hematology community! We’re proud to share that Blood Immunology & Cellular Therapy is now indexed in the Directory of Open Access Journals @doaj.bsky.social 🥳 Explore the latest from Blood ICT: ashpublications.org/bloodict #DOAJ #BloodICT #HematologyResearch

131 3

Blood Journals Portfolio @bloodjournals.hematology.org · 12/03/2026

New issue of Blood out now! Featuring Orca-T to prevent GVHD, Gene expression profiling in ALCL, VEXAS Syndrome-associated anemia, and more. Explore here: ashpublications.org/blood/issue/...

020 2

Blood Journals Portfolio @bloodjournals.hematology.org · 11/03/2026

New issue of Blood Global Hematology out now! Featuring Gap in hematologic cancer burden analysis across South Asia, A growing global burden of multiple myeloma in young adults, CAR-T in resource-limited regions, and more. ashpublications.org/bloodglobal/...

020 2

Blood Journals Portfolio @bloodjournals.hematology.org · 10/03/2026

Did you know we have 8 newsletters? Whatever your specialty is within #hematology, we have the publication for you. Visit our subscription center, sign into your ASH account, and subscribe to some or all of our newsletters. That's brand new research, directly to your inbox! 📧

020 2